시장보고서
상품코드
1912160

BMP 2(골형성 단백질 2) 시장(2025년)

Global Bone Morphogenetic Protein (BMP) 2 Market Research Report 2025

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 BMP 2(골형성 단백질 2) 시장은 2024년 6억 9,700만 달러로 평가되었으며, 2031년까지 11억 2,000만 달러에 이를 것으로 예측됩니다.

이에 따라 2025년부터 2031년까지의 예측 기간에서 CAGR 6.77%를 기록할 전망입니다.

북미의 BMP 2(골형성 단백질 2) 시장은 2024년 4억 7,676만 달러에서 2031년까지 7억 5,400만 달러에 이를 것으로 예측되며, 2025년에서 2031년의 예측 기간 동안 CAGR 6.09%로 성장할 것으로 전망됩니다.

아시아태평양의 BMP 2(골형성 단백질 2) 시장은 2024년 1억 4,047만 달러에서 2031년까지 2억 5,059만 달러에 이를 것으로 예측되며, 2025년에서 2031년의 예측 기간 동안 CAGR 10.26%로 성장할 것으로 전망됩니다.

세계의 BMP 2(골형성 단백질 2) 시장의 주요 기업에는 Medtronic, Jiuyuan Gene Engineering, Cellumed 등이 있습니다. 2024년 기준으로 세계 3대 벤더의 수익 점유율은 약 98.84%를 차지했습니다.

본 보고서는 세계의 BMP 2(골형성 단백질 2) 시장에 대해 정량적 및 정성적 분석을 겸비한 종합적인 제시를 실시하는 것을 목적으로 하고 있습니다. 이에 따라, 독자의 BMP 2에 관한 사업 및 성장 전략 책정, 시장 경쟁 구도의 평가, 현행 마켓플레이스에서의 자사의 위치 분석, 그리고 정보에 근거한 사업 판단을 뒷받침합니다.

BMP 2(골형성 단백질 2) 시장의 규모, 추정 및 예측치는 2024년을 기준연도로 하여 2020년부터 2031년까지의 기간 동안의 과거 데이터와 예측 데이터에 근거해 수익(백만 달러) 단위로 제공됩니다. 본 보고서에서는 세계의 BMP 2(골형성 단백질 2) 시장을 종합적으로 세분화하고 있습니다. 지역별 시장 규모, 제품 유형별, 용도별 및 주요 기업별 시장 규모에 대해서도 제시합니다.

시장에 대한 깊은 이해를 위해 본 보고서는 경쟁 구도, 주요 경쟁사 및 각 시장 순위에 대한 프로파일을 제공합니다. 또한 기술 동향과 신제품 개발에 대해서도 논의했습니다.

본 보고서는 BMP 2(골형성 단백질 2) 관련 기업, 신규 진출기업 및 업계 체인 관련 기업에 대해 시장 전체 및 각 하위 부문(기업별, 유형별, 용도별, 지역별)의 수익에 관한 정보를 제공하여 시장 진입을 뒷받침합니다.

시장 세분화

기업별

  • Medtronic
  • Jiuyuan Gene Engineering
  • Cellumed

유형별 부문

  • 스폰지 담체
  • 하이드록시아파타이트 담체

용도별 부문

  • 척추고정술
  • 외상수술
  • 구강턱 안면수술
  • 재건수술

지역별 부문

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 아시아태평양
    • 중국
    • 한국
    • 동남아시아
    • 인도
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 러시아
    • 기타 유럽
  • 남미
    • 브라질
  • 중동 및 아프리카
    • 중동
    • 아프리카
CSM

자주 묻는 질문

  • 세계의 BMP 2(골형성 단백질 2) 시장 규모는 어떻게 예측되나요?
  • 북미의 BMP 2(골형성 단백질 2) 시장 규모는 어떻게 변할 것으로 예상되나요?
  • 아시아태평양의 BMP 2(골형성 단백질 2) 시장 규모는 어떻게 변할 것으로 예상되나요?
  • 세계의 BMP 2(골형성 단백질 2) 시장의 주요 기업은 어디인가요?
  • 2024년 기준으로 세계 BMP 2(골형성 단백질 2) 시장의 수익 점유율은 어떻게 되나요?

The global Bone Morphogenetic Protein (BMP) 2 market was valued at US$ 697 million in 2024 and is anticipated to reach US$ 1120 million by 2031, witnessing a CAGR of 6.77% during the forecast period 2025-2031.

North American market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 476.76 million in 2024 to reach $ 754 million by 2031, at a CAGR of 6.09% during the forecast period of 2025 through 2031.

Asia-Pacific market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 140.47 million in 2024 to reach $ 250.59 million by 2031, at a CAGR of 10.26% during the forecast period of 2025 through 2031.

The major global companies of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering, Cellumed, etc. In 2024, the world's top three vendors accounted for approximately 98.84% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Bone Morphogenetic Protein (BMP) 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Morphogenetic Protein (BMP) 2.

The Bone Morphogenetic Protein (BMP) 2 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bone Morphogenetic Protein (BMP) 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bone Morphogenetic Protein (BMP) 2 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Medtronic
  • Jiuyuan Gene Engineering
  • Cellumed

Segment by Type

  • Sponge Carrier
  • Hydroxyapatite Carrier

Segment by Application

  • Spinal Fusion
  • Trauma Surgery
  • Oral Maxillofacial Surgery
  • Reconstructive Surgery

Segment by Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • South Korea
    • Southeast Asia
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
  • Middle East & Africa
    • Middle East
    • Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bone Morphogenetic Protein (BMP) 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
    • 1.2.2 Sponge Carrier
    • 1.2.3 Hydroxyapatite Carrier
  • 1.3 Market by Application
    • 1.3.1 Global Bone Morphogenetic Protein (BMP) 2 Market Growth by Application: 2020 VS 2024 VS 2031
    • 1.3.2 Spinal Fusion
    • 1.3.3 Trauma Surgery
    • 1.3.4 Oral Maxillofacial Surgery
    • 1.3.5 Reconstructive Surgery
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Perspective (2020-2031)
  • 2.2 Global Bone Morphogenetic Protein (BMP) 2 Growth Trends by Region
    • 2.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region: 2020 VS 2024 VS 2031
    • 2.2.2 Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Region (2020-2025)
    • 2.2.3 Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Region (2026-2031)
  • 2.3 Bone Morphogenetic Protein (BMP) 2 Market Dynamics
    • 2.3.1 Bone Morphogenetic Protein (BMP) 2 Industry Trends
    • 2.3.2 Bone Morphogenetic Protein (BMP) 2 Market Drivers
    • 2.3.3 Bone Morphogenetic Protein (BMP) 2 Market Challenges
    • 2.3.4 Bone Morphogenetic Protein (BMP) 2 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Revenue
    • 3.1.1 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Revenue (2020-2025)
    • 3.1.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players (2020-2025)
  • 3.2 Global Top Bone Morphogenetic Protein (BMP) 2 Players by Company Type by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players Ranking by Bone Morphogenetic Protein (BMP) 2 Revenue
  • 3.4 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio
    • 3.4.1 Global Bone Morphogenetic Protein (BMP) 2 Market Concentration Ratio (CR3 and HHI)
    • 3.4.2 Global Top 3 Companies by Bone Morphogenetic Protein (BMP) 2 Revenue in 2024
  • 3.5 Global Key Players of Bone Morphogenetic Protein (BMP) 2 Head office and Area Served
  • 3.6 Global Key Players of Bone Morphogenetic Protein (BMP) 2, Product and Application
  • 3.7 Global Key Players of Bone Morphogenetic Protein (BMP) 2, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Type

  • 4.1 Global Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Type (2020-2025)
  • 4.2 Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Type (2026-2031)

5 Bone Morphogenetic Protein (BMP) 2 Breakdown Data by Application

  • 5.1 Global Bone Morphogenetic Protein (BMP) 2 Historic Market Size by Application (2020-2025)
  • 5.2 Global Bone Morphogenetic Protein (BMP) 2 Forecasted Market Size by Application (2026-2031)

6 North America

  • 6.1 North America Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
  • 6.2 North America Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031
  • 6.3 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025)
  • 6.4 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031)
  • 6.5 United States
  • 6.6 Canada
  • 6.7 Mexico

7 Europe

  • 7.1 Europe Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
  • 7.2 Europe Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031
  • 7.3 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025)
  • 7.4 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031)
  • 7.5 Germany
  • 7.6 France
  • 7.7 U.K.
  • 7.8 Italy
  • 7.9 Russia

8 Asia-Pacific

  • 8.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
  • 8.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Region: 2020 VS 2024 VS 2031
  • 8.3 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2020-2025)
  • 8.4 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2026-2031)
  • 8.5 China
  • 8.6 South Korea
  • 8.7 Southeast Asia
  • 8.8 India

9 South America

  • 9.1 South America Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
  • 9.2 South America Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031
  • 9.3 South America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025)
  • 9.4 South America Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031)
  • 9.5 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size (2020-2031)
  • 10.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Growth Rate by Country: 2020 VS 2024 VS 2031
  • 10.3 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2020-2025)
  • 10.4 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country (2026-2031)
  • 10.5 Middle East
  • 10.6 Africa

11 Key Players Profiles

  • 11.1 Medtronic
    • 11.1.1 Medtronic Company Details
    • 11.1.2 Medtronic Business Overview
    • 11.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Introduction
    • 11.1.4 Medtronic Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025)
    • 11.1.5 Medtronic Recent Development
  • 11.2 Jiuyuan Gene Engineering
    • 11.2.1 Jiuyuan Gene Engineering Company Details
    • 11.2.2 Jiuyuan Gene Engineering Business Overview
    • 11.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Introduction
    • 11.2.4 Jiuyuan Gene Engineering Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025)
  • 11.3 Cellumed
    • 11.3.1 Cellumed Company Details
    • 11.3.2 Cellumed Business Overview
    • 11.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Introduction
    • 11.3.4 Cellumed Revenue in Bone Morphogenetic Protein (BMP) 2 Business (2020-2025)

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제